Related Experiment Video
Updated: Apr 11, 2026
Cell-Free Dot Blot as a Practical and Adaptable Immunoassay Platform for the Detection of Antibody Response in Human and Animal Sera
Published on: May 23, 2025
Dot-immunobinding assay (Dot-Iba)
Sumi Surendran1, Annamma Mathai, Vishnampet Venkataraman Radhakrishnan
1Department of Pathology, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, 695 011, Kerala, India.
Insights
Dot-immunobinding assay (Dot-IBA) offers a simple, rapid, and highly specific method for diagnosing diseases like tuberculous meningitis. This cost-effective assay is ideal for resource-limited laboratories, demonstrating no false positives.
Area of Science:
- Immunodiagnostics
- Biotechnology
- Medical Laboratory Science
Background:
- The Dot-immunobinding assay (Dot-IBA) is a straightforward and reproducible immunodiagnostic technique.
- It involves immobilizing antibodies or antigens onto nitrocellulose membrane (NCM) discs for specimen testing.
- This method simplifies the detection of antigen-antibody complexes.
Purpose of the Study:
- To evaluate the efficacy and applicability of the Dot-immunobinding assay (Dot-IBA) as a diagnostic tool.
- To assess Dot-IBA's sensitivity, specificity, and practicality, particularly in resource-constrained settings.
- To compare Dot-IBA with other immunoassays for detecting circulating antigens and antibodies.
Main Methods:
- Antigen or antibody is directly applied to nitrocellulose membrane (NCM) discs.
- Specimens are incubated on the prepared discs to allow for antigen-antibody complex formation.
- Detection involves enzyme-conjugated antiglobulins and a substrate, visualized by a color change on the NCM.
Main Results:
- The Dot-IBA procedure is rapid, completing in 4-6 hours.
- It demonstrated an overall sensitivity of 60% for tuberculous meningitis diagnosis.
- The assay exhibited high specificity with no false positive results, making it suitable for paucibacillary diseases.
Conclusions:
- Dot-immunobinding assay (Dot-IBA) is a highly specific and rapid immunodiagnostic method.
- Its simplicity and low resource requirement make it ideal for laboratories in developing countries.
- Dot-IBA is particularly effective for diagnosing extrapulmonary tuberculosis and other paucibacillary diseases.
Abstract:
Dot-immunobinding assay (Dot-Iba) is a simple and highly reproducible immunodiagnostic method. Antibody or antigen is dotted directly onto nitrocellulose membrane (NCM) discs. The diagnostic material to be checked can be incubated on this disc. Presence of antigen-antibody complex in NCM discs can be directly demonstrated with enzyme-conjugated antiglobulins and substrate. Development of a purple-pink colored, insoluble substrate product in the nitrocellulose membrane will be considered a positive result in the assay. This assay allows the processing of multiple specimens at a time and the entire operational procedures required only 4-6 h. Dot-IBA is rapid and the technical steps involved in the assay are much simpler than the other immunoassays such as enzyme-linked immunosorbent assay in detecting circulating antigen and antibody in clinical samples. The Dot-Iba showed an overall sensitivity of 60 % for tuberculous meningitis diagnosis and no false positive results were encountered. Hence this assay is highly specific for the diagnosis of paucibacillary diseases like extrapulmonary tuberculosis. Dot-Iba is best suited to laboratories in developing world where there are constraints in laboratory resources.
Related Concept Videos
01:15Western Blotting
The technique begins with separating proteins from the sample using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), followed by protein transfer, immunoblotting, and finally, protein detection.
02:57Southern Blot
Denatured DNA fragments must be transferred onto a carrier membrane from the gel to make it accessible to a probe - a small ssDNA fragment complementary to the target DNA...